1: Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. Amended Safety Assessment of Fatty Acyl Sarcosines and Sarcosinate Salts as Used in Cosmetics. Int J Toxicol. 2021 Jul 6:10915818211023881. doi: 10.1177/10915818211023881. Epub ahead of print. PMID: 34225481.
2: Werneth M, Pani J, Hofbauer L, Pummer S, Weber MT, Pour G, Kählig H, Mayer- Helm B, Stepan H. Stereospecific Response of E/Z-isomers of N-Nitrososarcosine in LC-ESI-MS/MS. J Chromatogr Sci. 2021 Feb 23:bmab013. doi: 10.1093/chromsci/bmab013. Epub ahead of print. PMID: 33618358.
3: Shubin AV, Lesovaya EA, Kirsanov KI, Antoshina EE, Trukhanova LS, Gorkova TG, Belitsky GA, Yakubovskaya MG, Demidyuk IV. Re-Examination of the Esophageal Squamous Cell Carcinoma Model in Rats Induced by N-Nitrososarcosine Ethyl Ester Precursors. Bull Exp Biol Med. 2018 Mar;164(5):676-679. doi: 10.1007/s10517-018-4057-2. Epub 2018 Mar 26. PMID: 29577190.
4: National Toxicology Program. N-Nitrosamines (15 listings): N-Nitrososarcosine. Rep Carcinog. 2011;12:324. PMID: 21860517.
5: Cheng G, Wang M, Villalta PW, Hecht SS. Detection of 7-(2'-carboxyethyl)guanine but not 7-carboxymethylguanine in human liver DNA. Chem Res Toxicol. 2010 Jun 21;23(6):1089-96. doi: 10.1021/tx100062v. PMID: 20438065; PMCID: PMC3230219.
6: Derave W, Vanden Eede E, Hespel P, Carmella SG, Hecht SS. Oral creatine supplementation in humans does not elevate urinary excretion of the carcinogen N-nitrososarcosine. Nutrition. 2006 Mar;22(3):332-3. doi: 10.1016/j.nut.2005.10.004. Epub 2006 Jan 18. PMID: 16413752.
7: National Toxicology Program. N-Nitrososarcosine. Rep Carcinog. 2002;10:188-9. Update in: Rep Carcinog. 2004;11:III208. PMID: 15328587.
8: N-Nitrososarcosine. Rep Carcinog. 2004;11:III208. PMID: 21089938.
9: Wang DY, Xiang YY, Li XJ, Hashimoto M, Tanaka M, Sugimura H. Mxi1 is a potential cellular target of carcinogens and frequently mutated in experimental rat tumors and tumor cell lines. Pathol Int. 2000 May;50(5):373-83. doi: 10.1046/j.1440-1827.2000.01057.x. PMID: 10849326.
10: Cheng CF, Tsang CW. Separation of N-nitrosoamino acids by C18 reversed-phase ion-pair high-performance liquid chromatography and compatible detection by electrospray ionization mass spectrometry. J Chromatogr A. 1999 Jul 23;849(2):389-402. doi: 10.1016/s0021-9673(99)00610-x. PMID: 10457437.
11: Tricker AR. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. Eur J Cancer Prev. 1997 Jun;6(3):226-68. PMID: 9306073.
12: Wang DY, Xiang YY, Tanaka M, Shen Q, Sugimura H. Identification of cytokeratin subspecies altered in rat experimental esophageal tumors by subtractive cloning. Cancer Lett. 1996 Nov 12;108(1):119-27. doi: 10.1016/s0304-3835(96)04403-5. PMID: 8950218.